Hedge funds are buying these two big tech stocks while selling two rivals
Novanta Inc. (NASDAQ:NOVT) updated its financial guidance for the fourth quarter and full year 2025 on Thursday to reflect the effects of a recent equity issuance, according to a statement released via a Securities and Exchange Commission filing.
The company now expects non-GAAP adjusted diluted earnings per share for the fourth quarter to be in the range of $0.84 to $0.91, compared to its previous guidance of $0.87 to $0.93. For the full year 2025, Novanta forecasts adjusted diluted EPS between $3.21 and $3.28, revised from the earlier range of $3.24 to $3.30.
The updated guidance incorporates the impact of the equity issuance on the number of shares outstanding. For the fourth quarter of 2025, the company anticipates a weighted average diluted shares outstanding impact between 2.5 million and 2.6 million shares. For the full year 2025, the impact is expected to be between 0.6 million and 0.7 million shares. For the full year 2026, Novanta estimates the diluted shares outstanding impact will range from 4.7 million to 5.9 million shares.
There are no changes to the company’s GAAP revenue guidance or adjusted EBITDA guidance for the fourth quarter and full year 2025. Novanta continues to project GAAP revenue of $253 million to $257 million for the fourth quarter and $975 million to $979 million for the full year. Adjusted EBITDA guidance remains at $62 million to $65 million for the fourth quarter and $222 million to $225 million for the full year.
The company noted that it provides earnings guidance on a non-GAAP basis and does not provide comparable GAAP earnings guidance, except for revenue. Novanta cited the difficulty in forecasting certain items as the reason for not reconciling non-GAAP forward-looking measures to GAAP measures.
This information is based on a statement provided in a recent SEC filing.
In other recent news, Novanta Inc. announced the pricing of its public offering of 11 million tangible equity units at $50 each, raising approximately $550 million. This offering is set to close on November 12, 2025, and includes prepaid stock purchase contracts and senior amortizing notes due in 2028. Additionally, Novanta has granted underwriters a 30-day option to purchase up to an additional 1.65 million units to cover potential over-allotments. In a related development, the company has launched a public offering of these units, which are planned to be listed on Nasdaq under the symbol "NOVTU." Furthermore, Novanta’s Board of Directors has authorized a $200 million share repurchase program, increasing the total available capacity to $231 million. This program allows for repurchasing the company’s outstanding common shares through various methods, including open market transactions and privately negotiated deals. These developments reflect Novanta’s strategic financial maneuvers in the market.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.